Publikationen von Soni Savai Pullamsetti
Alle Typen
Zeitschriftenartikel (85)
2022
Zeitschriftenartikel
13, 827719 (2022)
Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry. FRONTIERS IN IMMUNOLOGY
Zeitschriftenartikel
23 (1), 546 (2022)
Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets? INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 2021
Zeitschriftenartikel
28 (1), 28 (2021)
In-Silico Design of a Novel Tridecapeptide Targeting Spike Protein of SARS-CoV-2 Variants of Concern. INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
Zeitschriftenartikel
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. NATURE REVIEWS CARDIOLOGY (2021)
Zeitschriftenartikel
131 (19), e136939 (2021)
Disrupted PI3K subunit p110 alpha signaling protects against pulmonary hypertension and reverses established disease in rodents. JOURNAL OF CLINICAL INVESTIGATION
Zeitschriftenartikel
144 (13), S. 1042 - 1058 (2021)
Epigenetic Regulation by Suv4-20h1 in Cardiopulmonary Progenitor Cells Is Required to Prevent Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease. CIRCULATION
Zeitschriftenartikel
13 (16), 4127 (2021)
Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression. CANCERS
Zeitschriftenartikel
18 (16), 8280 (2021)
Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
Zeitschriftenartikel
09, 639162 (2021)
Depletion of Numb and Numblike in Murine Lung Epithelial Cells Ameliorates Bleomycin-Induced Lung Fibrosis by Inhibiting the beta-Catenin Signaling Pathway. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Zeitschriftenartikel
57 (4), 1901192 (2021)
CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension. EUROPEAN RESPIRATORY JOURNAL
Zeitschriftenartikel
13 (2), 208 (2021)
Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. CANCERS
Zeitschriftenartikel
178 (1), S. 54 - 71 (2021)
Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy. BRITISH JOURNAL OF PHARMACOLOGY 2020
Zeitschriftenartikel
12 (12), 3528 (2020)
Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Adenocarcinoma and Its Silencing Is Associated with Impaired Prognosis. CANCERS
Zeitschriftenartikel
202 (10), S. 1445 - 1457 (2020)
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFR beta. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Zeitschriftenartikel
10 (4), 2045894020947283 (2020)
Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats. PULMONARY CIRCULATION
Zeitschriftenartikel
29 (157), 200134 (2020)
Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment. EUROPEAN RESPIRATORY REVIEW
Zeitschriftenartikel
52 (1), S. 9 - + (2020)
TGF-beta Signaling Promotes Tissue Formation during Cardiac Valve Regeneration in Adult Zebrafish. DEVELOPMENTAL CELL
Zeitschriftenartikel
10 (1), 12864 (2020)
Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension. SCIENTIFIC REPORTS
Zeitschriftenartikel
80 (19), S. 4199 - 4211 (2020)
Metastasis-Associated Protein 2 Represses NF-kappa B to Reduce Lung Tumor Growth and Inflammation. CANCER RESEARCH
Zeitschriftenartikel
130 (11), S. 5638 - 5651 (2020)
Hypoxia-inducible factor signaling in pulmonary hypertension. JOURNAL OF CLINICAL INVESTIGATION